Category

Global Human Drugs For Veterinary Use Market Size, Share, Opportunities And Trends By Medication Type (Antibiotics, Non-steroidal Anti-inflammatories, Opioid Pain Relievers, Chemotherapeutics, Others), By Drug Type (Penicillin, Prednisone And Prednisolone, Diazepam, Others) And Geography - Forecasts From 2019 To 2024

Published: Mar 2020 | Report Code:  KSI061612151 | Pages:  104

The global human drugs for veterinary use market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. There are drugs which are used in veterinary medicines but are utilized by humans as well. These drugs are also referred to as human drugs for veterinary use. Commonly used include antibiotics like penicillin, non-steroidal anti-inflammatories, opioid pain relievers, steroids and antiparasitic among others. Growing number of veterinary practitioners and growing pet healthcare services are driving the growth of the global human drugs for veterinary use market in the forecast period. Also, rising funding research programs will further emanate the market growth in the coming years and beyond.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global human drugs for veterinary use value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global human drugs for veterinary use market.

Major industry players profiled as part of the report are Merck KGaA, Darmstadt, Germany and/or its affiliates, Zoetis, Pfizer Inc. and Roche Products Pty Limited among others.

Segmentation

The global human drugs for veterinary use market has been analyzed through following segments:

By Medication Type

Antibiotics

Non-steroidal anti-inflammatories

Opioid pain relievers

Chemotherapeutics

Others


By Drug Type

Penicillin

Prednisone and Prednisolone

Diazepam

Others


By Geography

North America

USA

Canada

Mexico

Others


South America

Brazil

Argentina

Others


Europe

Germany

France

United Kingdom

Spain

Others


Middle East and Africa

Saudi Arabia

Israel

Others


Asia Pacific

China

Japan

South Korea

India

Others


Target audience

Manufacturers

Suppliers

Distributors

Service Providers

Government Agencies

Research Organizations

Consultants


Key insights offered

What will be the global human drugs for veterinary use market size from 2017 to 2023?

How are the major drivers and restraints affecting the global human drugs for veterinary use market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.

OUR CLIENTS